Characteristics of Local Immunity in Patients with Cancer of the Oral Cavity and Pharynx

Authors

May 25, 2024

Downloads

Cancer of the oral cavity and oropharynx in clinical practice is considered as a single oncopathology, treated as oropharyngeal cancer (OPR). This pathology occupies the 2nd place in the incidence rate among head and neck tumors in the Russian Federation [1]. The incidence of OFR in the Russian Federation is not the same: in the industrial districts, which include the Rostov region, it is high, which put the region in the top ten regions with a high incidence of this pathology.